Gene · 442890
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bridging miRNA Research with Clinical Applications in Cardiovascular Diseases: Advances in Delivery Systems and Therapeutic Strategies. | Mini Rev Med Chem | 2026 | 41239932 | PubTator, text mining | PubMed |
| Meta-analysis of differentially expressed non-coding RNA signatures (lncRNAs, miRNAs, and snoRNAs) in Parkinson's disease. | Behav Brain Res | 2026 | 41075875 | PubTator, text mining | PubMed |
| The Roles of myomiRs in the Pathogenesis of Sarcopenia: From Literature to In Silico Analysis. | Mol Biotechnol | 2026 | 40025274 | PubTator, text mining | PubMed |
| miR-548ac and miR-378j as Potential Diagnostic Biomarkers in Gastric Cancer: A Case-Control Study. | Middle East J Dig Dis | 2025 | 41788208 | PubTator, text mining | PubMed |
| Retraction: MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells. | Oncol Res | 2025 | 41502511 | PubTator, text mining | PubMed |
| MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. | Pharmaceuticals (Basel) | 2025 | 41471397 | PubTator, text mining | PubMed |
| Serum LncRNA XIST and miR-133b as non-invasive biomarkers for diagnosis and progression of Parkinson's disease. | J Neurogenet | 2025 | 41351434 | PubTator, text mining | PubMed |
| Isoform-Specific Transcriptomic Effects of miR-133A1, miR-133A2, and miR-133B in a Colorectal Cancer Cell Line. | Genes (Basel) | 2025 | 41300774 | PubTator, text mining | PubMed |
| Editorial: Methods in cellular neurobiology research. | Front Cell Neurosci | 2025 | 41229728 | PubTator, text mining | PubMed |
| Retraction: MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1. | Oncol Res | 2025 | 41179297 | PubTator, text mining | PubMed |
| Diet, nutrition, and healthy aging: Are miRNAs the link? A narrative review. | J Nutr Health Aging | 2025 | 41130025 | PubTator, text mining | PubMed |
| LncRNA LINC02381/miR-133b axis promotes tumorigenesis and predicts survival in pancreatic cancer. | Discov Oncol | 2025 | 41060561 | PubTator, text mining | PubMed |
| Omics characteristics and epigenetic modifications of adipose-derived stem cells. | J Biol Chem | 2025 | 41005477 | PubTator, text mining | PubMed |
| Circulating plasma microRNA expression profile: potential minimally invasive biomarker for early detection of coronary artery disease development. | Mol Biol Rep | 2025 | 40971045 | PubTator, text mining | PubMed |
| The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia. | IBRO Neurosci Rep | 2025 | 40959537 | PubTator, text mining | PubMed |
| Profibrotic Molecules Are Reduced in CRISPR-Edited Emery-Dreifuss Muscular Dystrophy Fibroblasts. | Cells | 2025 | 40940734 | PubTator, text mining | PubMed |
| [Layered double hydroxide-loaded si-NEAT1 regulates paclitaxel resistance and tumor-associated macrophage polarization in breast cancer by targeting miR-133b/PD-L1]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 40916533 | PubTator, text mining | PubMed |
| NMDAR inhibitor preconditioned mesenchymal stromal cell-derived extracellular vesicles enhance post-stroke recovery by targeting excitotoxicity and neuronal regeneration. | Front Cell Neurosci | 2025 | 40873771 | PubTator, text mining | PubMed |
| Human chorion and placental mesenchymal stem cells conditioned media suppress cell migration and invasion by inhibiting the PI3K/AKT pathway in cholangiocarcinoma. | Sci Rep | 2025 | 40858767 | PubTator, text mining | PubMed |
| Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. | Signal Transduct Target Ther | 2025 | 40804047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442890/papers?page=3